Cargando…

Comparable cancer‐relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer

BACKGROUND: Ductal carcinoma in situ (DCIS) comprises a diverse group of preinvasive lesions in the breast and poses a considerable clinical challenge due to lack of markers of progression. Genomic alterations are to a large extent similar in DCIS and invasive carcinomas, although differences in cop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergholtz, Helga, Kumar, Surendra, Wärnberg, Fredrik, Lüders, Torben, Kristensen, Vessela, Sørlie, Therese
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941529/ https://www.ncbi.nlm.nih.gov/pubmed/32671987 http://dx.doi.org/10.1002/cnr2.1248

Ejemplares similares

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
por: Muggerud, Aslaug Aa, et al.
Publicado: (2010)

Re-definition of claudin-low as a breast cancer phenotype
por: Fougner, Christian, et al.
Publicado: (2020)

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
por: Zhou, Wenjing, et al.
Publicado: (2013)

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
por: Borgquist, Signe, et al.
Publicado: (2015)

Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors
por: Bergholtz, Helga, et al.
Publicado: (2022)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer
por: Johnson, Kevin C., et al.
Publicado: (2015)

Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers
por: Fougner, Christian, et al.
Publicado: (2019)

In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden
por: Agustsson, Arnar S., et al.
Publicado: (2020)

A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ
por: Zhou, Wenjing, et al.
Publicado: (2013)

APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer
por: Sieuwerts, Anieta M., et al.
Publicado: (2019)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression
por: Xu, Haifeng, et al.
Publicado: (2021)

Invasive Micropapillary Carcinoma in Axillary Ectopic Breast and Synchronous Ductal Carcinoma In Situ in the Contralateral Breast
por: Oh, Seung Won, et al.
Publicado: (2017)

Synchronous invasive ductal carcinoma in encapsulated papillary ductal carcinoma
por: Regan, J.P., et al.
Publicado: (2016)

Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer
por: Riis, Margit LH, et al.
Publicado: (2010)

Synchronization in epidemic growth and the impossibility of selective containment
por: Budich, Jan C, et al.
Publicado: (2021)

Ductal Breast Carcinoma In Situ: Mammographic Features and Its Relation to Prognosis and Tumour Biology in a Population Based Cohort
por: Zhou, Wenjing, et al.
Publicado: (2017)

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
por: Fleischer, Thomas, et al.
Publicado: (2014)

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
por: Zhou, Wenjing, et al.
Publicado: (2010)

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
por: Tamimi, Rulla M, et al.
Publicado: (2008)

Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
por: Liu, Yang, et al.
Publicado: (2023)

Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study
por: Karakatsanis, Andreas, et al.
Publicado: (2023)

Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo
por: Wärnberg, Fredrik, et al.
Publicado: (2006)

LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target
por: Hagerling, Catharina, et al.
Publicado: (2020)

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma
por: Fleischer, Thomas, et al.
Publicado: (2013)

Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2017)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

Metastatic Prostate Cancer Synchronous with Male Breast Papillary Ductal Carcinoma in situ: Management Dilemma and Literature Review
por: Hasbullah, Harissa Husainy, et al.
Publicado: (2021)

Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
por: Doebar, S. C., et al.
Publicado: (2018)

Combining Gene Signatures Improves Prediction of Breast Cancer Survival
por: Zhao, Xi, et al.
Publicado: (2011)

Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma
por: Lee, Jeeyeon, et al.
Publicado: (2020)

Sharp Downregulation of Hub Genes Associated With the Pathogenesis of Breast Cancer From Ductal Carcinoma In Situ to Invasive Ductal Carcinoma
por: Wang, Yao, et al.
Publicado: (2021)

Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer
por: Tahiri, Andliena, et al.
Publicado: (2020)

Molecular Profiles of Pre- and Postoperative Breast Cancer Tumours Reveal Differentially Expressed Genes
por: Riis, Margit L. H., et al.
Publicado: (2012)

The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin
por: Schnitt, Stuart J
Publicado: (2009)

Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer
por: Afghahi, Anosheh, et al.
Publicado: (2015)

Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer
por: Park, Ko Woon, et al.
Publicado: (2022)

Machine Learning Algorithm for Distinguishing Ductal Carcinoma In Situ from Invasive Breast Cancer
por: Vy, Vu Pham Thao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g0gaomgg00o757g3ci6rcfg3co